Cyclic GMP-specific phosphodiesterase inhibitors
US6825197B2 · kind B2 · utility
8Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 2002 |
| Grant date | Nov 30, 2004 |
| Priority date | — |
| Expiry date | Jan 11, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of general structural formula (I) and use of the compounds and salts and solvates thereof, as therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.